How to Buy Kalaris Therapeutics Stock
Kalaris Therapeutics Inc
Kalaris Therapeutics Inc operates as a pharmaceutical company. The Company specializes in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.
Kalaris Therapeutics stock last closed at $6.27, down 9.13% from the previous day, and has decreased 65.68% in one year. It has overperformed other stocks in the Biotechnology industry by 0.11 percentage points. Kalaris Therapeutics stock is currently +6.91% from its 52-week low of $5.87, and -74.04% from its 52-week high of $24.15.
As of Apr 30, 2025, there are 5.04M shares of KLRS outstanding. The market cap of KLRS is $31.62M. In the past 24 hours, 24,807 KLRS shares were traded.
How to Buy Kalaris Therapeutics Stock
Not sure how to invest in Kalaris Therapeutics stock? Here's how.
- Choose where to buy Kalaris Therapeutics stock: You need to pick an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you choose where to buy Kalaris Therapeutics stock.
- Open your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Fund your investment account: Pick your method of payment and add your info.
- Analyze Kalaris Therapeutics stock: The Kalaris Therapeutics ticker symbol is KLRS. Is Kalaris Therapeutics stock a good investment? Should you buy shares of KLRS? How do KLRS's underlying business fundamentals look? Do top analysts think Kalaris Therapeutics is a good buy? Why has KLRS's stock price moved recently? (Hint: Our stock market analysis tools can help you decide if KLRS is a good stock to buy).
- Execute your KLRS trade: Decide if you will purchase KLRS shares at the current market price or use a limit order to buy KLRS stock at a particular price.
- Keep tabs on your KLRS position: Create a watchlist to watch your new investment in Kalaris Therapeutics shares.
Step 1: Choose where to buy Kalaris Therapeutics stock
You will need a brokerage account in order to access the NASDAQ market and buy KLRS shares.
Our favorite brokerage: eToro
We believe that eToro is the best place to buy stocks. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to world financial markets: From Tech to Financial Services, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open your brokerage account
Now that you've chosen the best brokerage, you'll need to fill out some personal details so you can buy KLRS stock today.
How to Create a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal details to open a new trading account.
- Submit your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you've opened your account on apps for stocks, you need to deposit funds:
Check out the video below to see the process of depositing funds into your investment account.
Step 4: Analyze Kalaris Therapeutics stock
After you have decided on the best place to buy Kalaris Therapeutics stock, it's crucial to analyze their stock prior to investing, so you can wrap your head around the risk and opportunity.
Kalaris Therapeutics shares at a glance
Kalaris Therapeutics Due Diligence Score
WallStreetZen was designed to help average investors do more accurate fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on KLRS's stock page.
How is KLRS stock valued?
Analysts use many financial metrics, analyses, models, and charts to gauge KLRS's intrinsic value.
Using relative valuations methods:
- KLRS may be undervalued based on its P/B ratio of 0.28x, relative to Biotechnology industry P/B ratio of 4.45x
You can access additional valuation research on KLRS's stock here.
KLRS Financials at a glance
Positive Health Checks:
- KLRS has a low debt to equity ratio of 0.05.
- Total KLRS debt is lower than 5 years ago, relative to shareholder equity.
- KLRS has $118.29M in cash and short term investments. This is enough to cover its annual cash burn of $67.71M.
- KLRS has cash burn of 67705000. It has enough cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the KLRS balance sheet.
- There are more short-term assets than long-term liabilities on the KLRS balance sheet.
You can dive deeper into what analysts are forecasting on the Kalaris Therapeutics stock forecast page.
KLRS Technicals
KLRS Revenue
Last year, KLRS revenue was $0.00. Over the last 5 year, KLRS's revenue has gone up by -100% per year. This was slower than the Biotechnology industry average of 45.66%.
You can research KLRS's earnings and revenue performance here.
Who is buying/selling KLRS?
Over the past year, insiders at KLRS have sold more shares than they have bought.
Brett R. Hagen, Chief Accounting Officer of KLRS, was the latest KLRS insider to sell. They sold $8,134.88 worth of KLRS stock on Mar 26, 2025.
Learn more about who owns KLRS stock here.
Can I get consistent income from KLRS stock?
No, Kalaris Therapeutics doesn't provide an income stream by paying out dividends.
KLRS Social Trading Data
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Execute your KLRS trade
You have two main types of orders:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are mostly the best for newer investors. - Limit order: A limit order allows you to buy or sell a security at a specific price (or better).
If you want to ensure you're buying or selling at a particular dollar amount limit, place a limit order.
Click the Open button and eToro will execute the order.
If you want additional info about buying stocks on eToro, watch the helpful video below:
Step 6: Keep tabs on your KLRS position
Now that you own some KLRS shares, you'll want to stay up-to-date on your new investment.
Start a watchlist to see the latest developments about your KLRS stock.
KLRS Feed
How to Buy Stock in Kalaris Therapeutics
To reiterate, here are the 6 steps to buy Kalaris Therapeutics stock:
- Choose where to buy Kalaris Therapeutics stock
- Open your brokerage account
- Fund your investment account
- Analyze Kalaris Therapeutics stock
- Execute your KLRS trade
- Keep tabs on your KLRS position
If you require a brokerage account, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get updates on your new investment in Kalaris Therapeutics, hit the button below to create your watchlist.
Other Content You Might Like
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.